A detailed history of Personal Cfo Solutions, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 21,088 shares of AZN stock, worth $1.38 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
21,088
Previous 21,046 0.2%
Holding current value
$1.38 Million
Previous $1.64 Million 0.12%
% of portfolio
0.23%
Previous 0.26%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $3,220 - $3,680
42 Added 0.2%
21,088 $1.64 Million
Q2 2024

Aug 09, 2024

BUY
$66.81 - $80.83 $388,366 - $469,864
5,813 Added 38.16%
21,046 $1.64 Million
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $57,856 - $65,952
948 Added 6.64%
15,233 $1.03 Million
Q4 2023

Feb 13, 2024

SELL
$61.89 - $69.28 $21,042 - $23,555
-340 Reduced 2.32%
14,285 $962,000
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $117,897 - $130,350
-1,818 Reduced 11.06%
14,625 $990,000
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $27,055 - $29,338
-387 Reduced 2.3%
16,443 $1.18 Million
Q1 2023

May 09, 2023

BUY
$63.15 - $71.6 $89,988 - $102,029
1,425 Added 9.25%
16,830 $1.17 Million
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $64,726 - $84,105
-1,194 Reduced 7.19%
15,405 $1.04 Million
Q3 2022

Nov 01, 2022

BUY
$53.02 - $135.75 $880,078 - $2.25 Million
16,599 New
16,599 $910,000
Q1 2021

Apr 21, 2021

SELL
$47.16 - $54.44 $217,030 - $250,532
-4,602 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$48.52 - $58.02 $6,889 - $8,238
142 Added 3.18%
4,602 $230,000
Q3 2020

Nov 02, 2020

BUY
$53.07 - $61.1 $7,854 - $9,042
148 Added 3.43%
4,460 $0
Q2 2020

Aug 03, 2020

BUY
$43.1 - $55.31 $185,847 - $238,496
4,312 New
4,312 $228,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.